Tags |
|
|
Links |
|
|
Main Subject - CEO: The Key To Fix ingThe Marketing/Sales Collaboration Problem
We all know that achieving better alignment, synergy and cooperation between company marketing and sales departments is vital, but oh so elusive. Despite all the talk and more talk in the media and at national business gatherings, nothing significant ever seems to happen.
The reason nothing happens is that there is only one person who can truly mak
The reason nothing happens is that there is only one person who can truly mak
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
e it happen: The Company CEO. Unfortunately, CEOs don’t seem to be getting the message.
Why is the CEO the key?
In virtually every company, the president or CEO is responsible for setting the primary direction and goals for all parts of that company’s operations. Many CEOs practice a macro style of management, delegating many of their responsibili
Why is the CEO the key?
In virtually every company, the president or CEO is responsible for setting the primary direction and goals for all parts of that company’s operations. Many CEOs practice a macro style of management, delegating many of their responsibili
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ties to others, which is usually good. But delegating does not absolve them of using their influence over major changes in the company. The CEO is ultimately the weathervane for determining what does and doesn’t get done – especially major changes, like getting better marketing and sales collaboration.
What is happening?
Left to their own devices,
What is happening?
Left to their own devices,
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
sales managers and marketing managers will continue to work separately while feigning collaboration. Numerous software providers have given these managers an easy way to avoid having to seriously collaborate person-to-person. These providers champion the solution of having a Customer Relationship Management program in place. CRM has its merits and s
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ome have found it successful, but the jury stills seems to be out on how applicable it is to this problem. While we wait for more data, I don’t see significant change in selling/marketing habits or department cooperation. There is still no serious collaboration on permanent change.
Other vendors say the answer is to develop new customer-centered me
Other vendors say the answer is to develop new customer-centered me
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ssaging. This will bring success, they say, with both departments centered on knowing what the customer wants, needs and feels about the company. From what I hear, this idea hasn’t found great success either. Perhaps it’s not successful because it is left to each department to interpret how it sees and uses this messaging information. Perhaps it is
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ecause message-centering isn’t a strong enough mandate for permanent change in both departments’ behavior.
I maintain that if an idea, technology, or policy suggests a significant change in the importance, behavior or role of either department, it probably won’t get priority attention.
We can paint a new target color on prospects, describe them in
I maintain that if an idea, technology, or policy suggests a significant change in the importance, behavior or role of either department, it probably won’t get priority attention.
We can paint a new target color on prospects, describe them in
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
different detail, or agree on new messages, but what will motivate marketing and sales departments to tear down their silos? What motivates them to overcome their own lack of knowledge and fears about the other’s role and importance? What’s in it for them? After all, it took decades to build these departments, and we don’t easily eliminate territor
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ial imperatives in corporate America.
Do Marketing and/or Sales Vice Presidents see this problem?
Here are some interesting observations:
a. In a recent survey, 40% of Chief Marketing Officers (CMO) said they can’t/won’t measure the effectiveness of their own marketing programs.
b. In that same survey, 39% of these CMOs said their department doe
Do Marketing and/or Sales Vice Presidents see this problem?
Here are some interesting observations:
a. In a recent survey, 40% of Chief Marketing Officers (CMO) said they can’t/won’t measure the effectiveness of their own marketing programs.
b. In that same survey, 39% of these CMOs said their department doe
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
n’t work well with their sales department.
c. Sales departments said 70% of their marketing materials end up in the trash. (If the marketing budget makes up 23% of the average company’s revenues, that’s a lot of money going down the drain.)
If Sales and Marketing Vice Presidents agree on this problem, why no action?
1. Nobody relishes accepting a
c. Sales departments said 70% of their marketing materials end up in the trash. (If the marketing budget makes up 23% of the average company’s revenues, that’s a lot of money going down the drain.)
If Sales and Marketing Vice Presidents agree on this problem, why no action?
1. Nobody relishes accepting a
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nd addressing a major department behavioral change. This is hard, time-consuming and strange territory for most.
2. There is real career risk and fear in either person taking the initiative.
3. Most don’t have the depth of knowledge about how to make this type of change.
4. Day-to-day activities give good excuses for not focusing adequately on th
2. There is real career risk and fear in either person taking the initiative.
3. Most don’t have the depth of knowledge about how to make this type of change.
4. Day-to-day activities give good excuses for not focusing adequately on th
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
is.
Most importantly, why doesn’t the CEO get involved?
Several possibilities exist:
• Maybe the substantial dollar value of the results from this change isn’t clear enough.
• Maybe CEOs enjoy being “referee” for these two department squabbles.
• Maybe CEOs fear making a wrong decision.
• Maybe they believe some new technology will be the answ
Most importantly, why doesn’t the CEO get involved?
Several possibilities exist:
• Maybe the substantial dollar value of the results from this change isn’t clear enough.
• Maybe CEOs enjoy being “referee” for these two department squabbles.
• Maybe CEOs fear making a wrong decision.
• Maybe they believe some new technology will be the answ
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
r.
• Maybe CEOs don’t understand change in marketing and sales actions are essential in today’s marketplace.
What will work:
During my 25+ years of business development experience in 50 different industries, I’ve had a lot of first-hand experience with the “corporate silo issues” and bickering between marketing and sales departments. I’ve seen sh
• Maybe CEOs don’t understand change in marketing and sales actions are essential in today’s marketplace.
What will work:
During my 25+ years of business development experience in 50 different industries, I’ve had a lot of first-hand experience with the “corporate silo issues” and bickering between marketing and sales departments. I’ve seen sh
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ocking, contradictory answers to the question of a company’s key competitive advantages as expressed by these two departments.
Buying new software or adopting some new pictures, slogans and buzz terms for prospect/customers is NOT the most important first step. The keys to solving this collaboration problem are simple and very doable:
1. The CEO m
Buying new software or adopting some new pictures, slogans and buzz terms for prospect/customers is NOT the most important first step. The keys to solving this collaboration problem are simple and very doable:
1. The CEO m
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ust accept that bold change within these two departments is vital and that he or she must personally start this ball rolling.
2. The CEO must believe certain changes in behavior, attitude, knowledge base and work procedures are essential for any effort to be fruitful.
3. The CEO must initiate and set the expectations and measurements.
4. The CEO
2. The CEO must believe certain changes in behavior, attitude, knowledge base and work procedures are essential for any effort to be fruitful.
3. The CEO must initiate and set the expectations and measurements.
4. The CEO
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ust expedite the hiring of an outside facilitator who can quickly establish credibility and leadership with both departments.
My approach is built on proven employee change techniques, tweaked to fit this current challenge. The key success components are:
- Getting both departments to see personal benefits in significantly changing their business
My approach is built on proven employee change techniques, tweaked to fit this current challenge. The key success components are:
- Getting both departments to see personal benefits in significantly changing their business
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
behavior, activities and responsibilities
- Having department individuals build the plan for change together
- Moving both departments closer together physically
- Facilitating cross-training between departments
What’s in it for the CEO?
The CEO has a heavy stake in sales and marketing department collaboration. When these departments finally wo
- Having department individuals build the plan for change together
- Moving both departments closer together physically
- Facilitating cross-training between departments
What’s in it for the CEO?
The CEO has a heavy stake in sales and marketing department collaboration. When these departments finally wo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
rk together, the way they should:
1. ROI for both departments will improve and be much clearer.
2. Marketing and sales costs will be reduced.
3. Sales revenues will jump noticeably.
I believe most CEOs are tired of the mediocre sales growth that comes from departmental struggles and constant finger pointing. It is time they get the message: It d
1. ROI for both departments will improve and be much clearer.
2. Marketing and sales costs will be reduced.
3. Sales revenues will jump noticeably.
I believe most CEOs are tired of the mediocre sales growth that comes from departmental struggles and constant finger pointing. It is time they get the message: It d
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
esn’t have to be this way.
###
Sidebar
What are the key considerations for successful implantation of this corporate change?
1. The outside facilitator must have balanced credibility in both the marketing and sales professions. Insiders can’t do it themselves (This has been tried but failed because one or the other department felt pressured to f
###
Sidebar
What are the key considerations for successful implantation of this corporate change?
1. The outside facilitator must have balanced credibility in both the marketing and sales professions. Insiders can’t do it themselves (This has been tried but failed because one or the other department felt pressured to f
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
avor one department’s philosophy or the other).
2. The CEO must agree on what constitutes quantifiable measures of performance and return on investment. (A good facilitator will help here.)
3. The employees must design, agree and implement the new collaboration action plan. They must “own” and drive it, not management.
© Rick Wemmers 770-565-872
2. The CEO must agree on what constitutes quantifiable measures of performance and return on investment. (A good facilitator will help here.)
3. The employees must design, agree and implement the new collaboration action plan. They must “own” and drive it, not management.
© Rick Wemmers 770-565-872
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24658/mainsubjects-CEO-The-Key-To-Fix-ingThe-MarketingSales-Collaboration-Problem.html">CEO: The Key To Fix ingThe Marketing/Sales Collaboration Problem</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24658/mainsubjects-CEO-The-Key-To-Fix-ingThe-MarketingSales-Collaboration-Problem.html]CEO: The Key To Fix ingThe Marketing/Sales Collaboration Problem[/url]
Related Articles:
Bookmark it:
|